Related references
Note: Only part of the references are listed.Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
David J. Gallagher et al.
CLINICAL CANCER RESEARCH (2010)
Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
Ilir Agalliu et al.
CLINICAL CANCER RESEARCH (2009)
Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin
Catarina Santos et al.
FAMILIAL CANCER (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Roger L. Milne et al.
CLINICAL CANCER RESEARCH (2008)
BRCA1 mutations and prostate cancer in Poland
Cezary Cybulski et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
Julius Gudmundsson et al.
NATURE GENETICS (2007)
Common variation in the BRCA1 gene and prostate cancer risk
Julie A. Douglas et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Meredith Yeager et al.
NATURE GENETICS (2007)
Multiple regions within 8q24 independently affect risk for prostate cancer
Christopher A. Haiman et al.
NATURE GENETICS (2007)
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Julius Gudmundsson et al.
NATURE GENETICS (2007)
A common 8q24 variant in prostate and breast cancer from a large nested case-control study
Fredrick R. Schumacher et al.
CANCER RESEARCH (2007)
Cancer risks among BRCA1 and BRCA2 mutation carriers
E. Levy-Lahad et al.
BRITISH JOURNAL OF CANCER (2007)
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Matthew L. Freedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A common variant associated with prostate cancer in European and African populations
Laufey T. Amundadottir et al.
NATURE GENETICS (2006)
Prevalent mutations in prostate cancer
JT Dong
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
BRCA mutations and risk of prostate cancer in Ashkenazi Jews
T Kirchhoff et al.
CLINICAL CANCER RESEARCH (2004)
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
A Liede et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
BL Niell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
RM Giusti et al.
JOURNAL OF MEDICAL GENETICS (2003)
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland -: art. no. e98
T Ikonen et al.
JOURNAL OF MEDICAL GENETICS (2003)
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits
S Purcell et al.
BIOINFORMATICS (2003)
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
A. Vezina et al.
BRITISH JOURNAL OF CANCER (2000)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
